Inactive Instrument

News Kane Biotech Inc Other OTC

Equities

CA4838091094

End-of-day quote Other OTC Other stock markets
- ^USD	-

Jul. 11	Kane Biotech Signs a License Agreement with Omni Bioceutical For Its Scalp Care Products	MT
Jul. 11	Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kane Biotech Signs a License Agreement with Omni Bioceutical For Its Scalp Care Products	Jul. 11	MT
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.	Jul. 11	AQ
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc	Jul. 11	CI
Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel	Jun. 27	MT
Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel to ProgenaCare Global	Jun. 27	MT
Kane Biotech Brief: Says Made First Commercial Sale of revyve Antimicrobial Wound Gel to ProgenaCare Global	Jun. 27	MT
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global	Jun. 27	AQ
Kane Biotech Makes First Commercial Sale of revyve? Antimicrobial Wound Gel to ProgenaCare Global	Jun. 27	CI
Kane Biotech Signs License Agreement with I-MED Pharma	Jun. 25	MT
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.	Jun. 25	AQ
Kane Biotech Signs Worldwide License Agreement with I-MED Pharma Inc	Jun. 25	CI
Kane Biotech Q1 Loss Widens Despite Revenue Gains; to Report a Q2 Gain Following Sale of STEM Animal Health	May. 23	MT
Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
Kane Biotech Announces First Quarter 2024 Financial Results	May. 23	GL
Transcript : Kane Biotech Inc. - Shareholder/Analyst Call	May. 22
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024	May. 16	AQ
Kane Biotech Expands Wound Care Portfolio with Patented Schultz Biofilm Wound Map	May. 15	MT
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	May. 15	GL
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map	May. 15	AQ
Transcript : Kane Biotech Inc. - Special Call	Apr. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kane Biotech Inc Other OTC

Equities

CA4838091094

Summary

Filters